Abstract
Open heart surgery with mechanical or porcine bioprosthetic valve replacement is the current gold-standard therapeutic approach for the vast majority of patients with severe aortic valve disease, offering symptomatic relief and improving long-term survival. However, the etiology of aortic stenosis in the Western population is primarily degenerative, and patients are typically elderly with multiple co-morbid conditions which increase surgical risk [1–3]. In high-risk patients with baseline features such as left ventricular failure, concomitant coronary artery disease, prior bypass graft surgery, chronic obstructive pulmonary disease and/or advanced age, expected operative mortality ranges from 10% to even 50% in high-risk patients subgroups [1]. Moreover, surgery is often not performed in high-risk patients. In the Euro Heart Survey, up to 33% of patients in NYHA functional class III/IV with a single diseased valve were declined for surgery or were never considered as surgical candidates, due to an expected short life expectancy and associated comorbid conditions [4]. alternative techniques for treatment of high-risk patients are therefore needed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gabrielle F, Gams E, Harjula A, Jones MT, Pintor PP, Salamon R, Thulin L (1999) Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15(6):816–822
Culliford AT, Galloway AC, Colvin SB, et al (1991) Aortic valve replacement for aortic stenosis in persons aged 80 years and over. Am J Cardiol 67:1256–1260
Kvidal P, Bergström R, Hörte L-G, Stahle E (2000) Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 35:747–756
Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A (2003) A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24(13):1231–1243
Andersen HR, Knudsen LL, Hasemkam JM (1992) Transluminal implantation of artificial heart valves: description of a new expandable aortic valve and initial results with implantation by catheter techniques in closed chest pigs. Eur Heart J 13:704–708
Bonhoeffer P, Boudjemline Y, Saliba Z, Hausse AO, Aggoun Y, Bonnet D, Sidi D, Kachaner J (2000) Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. Circulation 102:813–816
Boudjemline Y, Bonhoeffer P (2000) Steps toward percutaneous aortic valve replacement. Circulation 105:775–776
Boudjemline Y, Bonhoeffer P (2002) Percutaneous implantation of a valve in the descending aorta in lambs. Eur Heart J 23:1045–1049
Sochman J, Peregrin JH, Pavnick D, Timmermans H, Rosch J (2000) Percutaneous transcatheter aortic disc valve prosthesis implantation: a feasibility study. Cardiovasc Intervent Radiol 23:384–388
Cribier A, Eltchaninoff H, Borenstein N (2001) Transcatheter implantation of balloon expandable prosthetic heart valves: early results in an animal model. Circulation 104:II552 (abstract)
Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis. Circulation 106(24): 3006–3008
Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, Bash A, Nusimovici D, Litzler PY, Bessou JP, Leon MB (2004) Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. JACC 43(4):698–703
Bauer F, Eltchaninoff H, Tron C, Lesault PF, Agatiello C, Nercolini D, Derumeaux G, Cribier A (2004) Acute improvement in global and regional left ventricular systolic function after percutaneous heart valve implantation in patients with symptomatic aortic stenosis. Circulation 110(11):1473–1476
Grube E, Laborde JC, Zickmann B, Gerckens U, Felderhoff T, Sauren B, Bootsveld A, Buellesfeld L, Iversen S (2005) First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treament of aortic valve stenosis. Catheter Cardiovasc Interv 66(4):465–469
Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW (2006) Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 114(15): 1616–1624
Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second-and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50(1):69–76. Epub 2007 Jun 6
Haas PC, Krajcer Z, Diethrich EB (1999) Closure of large percutaneous access sites using the Prostar XL Percutaneous Vascular Surgery device. J Endovasc Surg 6(2):168–170
Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys P (2008) Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroInterv 4:242–249
Grube E, Gerckens U (2008) Retrograde transfemoral aortic valve replacement — from early device prototypes to a routine cath lab procedure. Data on CoreValve registry presented at TCT, Washington, 12th–17th October 2008
Dawkins S, Hobson AR, Kalra PR, Tang AT, Monro JL, Dawkins KD (2008) Permanent pacemaker implantation after isolated aortic valve replacement: incidence, indications, and predictors. The Annals of thoracic surgery 85(1):108–112
Koplan BA, Stevenson WG, Epstein LM, Aranki SF, Maisel WH (2003) Development and validation of a simple risk score to predict the need for permanent pacing after cardiac valve surgery. Journal of the American College of Cardiology 41(5):795–801
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gerckens, U. et al. (2010). Percutaneous transluminal aortic valve replacement: The CoreValve prosthesis. In: Yankah, C.A., Weng, Y., Hetzer, R. (eds) Aortic Root Surgery. Steinkopff. https://doi.org/10.1007/978-3-7985-1869-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-7985-1869-8_3
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-1868-1
Online ISBN: 978-3-7985-1869-8
eBook Packages: MedicineMedicine (R0)